Omalizumab



Omalizumab





See Appendix R, Less commonly used drugs.


Omega-3-Acid Ethyl Esters

(oh may gah-three-ass’ id)

Lovaza

PREGNANCY CATEGORY C


Drug Classes

Lipid-lowering drug

Omega-3 fatty acid


Therapeutic Actions

Inhibits liver enzyme systems leading to a decrease in the synthesis of triglycerides in the liver, lowering serum triglyceride levels.


Indications



  • As an adjunct to diet to reduce very high (greater than 500 mg/dL) triglyceride levels in adult patients



Available Forms

Capsules—1 g


Dosages

Adults

4 g/day PO taken as a single dose (4 capsules) or divided into two doses—2 capsules PO bid.

Pediatric patients

Safety and efficacy not established.

Jul 21, 2016 | Posted by in NURSING | Comments Off on Omalizumab

Full access? Get Clinical Tree

Get Clinical Tree app for offline access